We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+29.22%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$999B
AUM Growth
+$134B
Cap. Flow
-$3.54B
Cap. Flow %
-0.35%
Top 10 Hldgs %
32.24%
Holding
3,356
New
224
Increased
2,237
Reduced
645
Closed
116

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.1B
2
AAPL icon
Apple
AAPL
+$11.6B
3
AMZN icon
Amazon
AMZN
+$3.54B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.07B
5
KEYS icon
Keysight
KEYS
+$1.82B

Sector Composition

Rank Sector Weight
1 Technology 37.73%
2 Healthcare 11.3%
3 Financials 10.32%
4 Communication Services 9.66%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
151
Progressive
PGR
$119B
$1.12B 0.11%
5,126,343
-15,474
-0.3% -$3.12M
WMB icon
152
Williams Companies
WMB
$84.7B
$1.11B 0.11%
14,897,067
-1,033,096
-6% -$76M
MEDP icon
153
Medpace
MEDP
$17.3B
$1.1B 0.11%
2,069,677
+1,780,170
+615% +$822M
FN icon
154
Fabrinet
FN
$15B
$1.09B 0.11%
1,940,957
-1,901,863
-49% -$1.23B
VTRS icon
155
Viatris
VTRS
$20.5B
$1.08B 0.11%
68,214,436
+2,350,332
+4% +$36.4M
IBM icon
156
IBM
IBM
$212B
$1.08B 0.11%
3,828,617
-1,041,744
-21% -$262M
TCAF icon
157
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.83B
$1.07B 0.11%
26,042,943
+1,777,139
+7% +$70.2M
ETN icon
158
Eaton
ETN
$171B
$1.06B 0.11%
2,497,387
+1,585,861
+174% +$640M
RRC icon
159
Range Resources
RRC
$9.02B
$1.05B 0.11%
28,248,416
+1,053,115
+4% +$42.8M
AXON
160
Axon Enterprise
AXON
$34.9B
$1.05B 0.11%
1,871,812
+1,083,176
+137% +$453M
CEG icon
161
Constellation Energy
CEG
$93.3B
$1.05B 0.1%
4,219,123
-1,255,200
-23% -$353M
PLD icon
162
Prologis
PLD
$126B
$1.05B 0.1%
7,732,377
-1,443,554
-16% -$205M
SWK icon
163
Stanley Black & Decker
SWK
$13.8B
$1.04B 0.1%
11,055,174
+1,023,442
+10% +$80.2M
AON icon
164
Aon
AON
$59B
$1.04B 0.1%
3,136,640
+1,855,714
+145% +$599M
CNQ icon
165
Canadian Natural Resources
CNQ
$97.7B
$1.03B 0.1%
26,101,709
+3,094,883
+13% +$141M
AIG icon
166
American International
AIG
$38.8B
$1.03B 0.1%
13,777,317
-97,989
-0.7% -$7.45M
VLO icon
167
Valero Energy
VLO
$111B
$1.02B 0.1%
3,924,248
-4,209,220
-52% -$1.04B
MIDD icon
168
Middleby
MIDD
$4.87B
$1B 0.1%
5,814,110
-600,291
-9% -$90.5M
ESS icon
169
Essex Property Trust
ESS
$17.5B
$979M 0.1%
3,357,197
+8,488
+0.3% +$2.28M
CTAS icon
170
Cintas
CTAS
$79.9B
$978M 0.1%
5,750,996
+8,646
+0.2% +$1.49M
GH icon
171
Guardant Health
GH
$23.8B
$977M 0.1%
6,514,952
-508,737
-7% -$55.3M
DELL icon
172
Dell
DELL
$358B
$970M 0.1%
2,249,000
+931,351
+71% +$269M
LHX icon
173
L3Harris
LHX
$44.3B
$957M 0.1%
3,294,631
-453,728
-12% -$144M
REGN icon
174
Regeneron Pharmaceuticals
REGN
$81.1B
$954M 0.1%
1,529,709
-647,818
-30% -$441M
GWW icon
175
W.W. Grainger
GWW
$58.5B
$944M 0.09%
694,196
-211,226
-23% -$260M

Similar funds

T. Rowe Price Associates's Q2 2026 Portfolio in Review

As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
  • T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
  • T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
  • T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
  • T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
  • T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.